Piper Jaffray Downgrades Eagle Pharmaceuticals (EGRX) to Neutral

October 31, 2018 3:11 AM

Piper Jaffray analyst David Amsellem downgraded Eagle Pharmaceuticals (NASDAQ: EGRX) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found